Pyxis Oncology, Inc. (PYXS)
NASDAQ·Healthcare·Biotechnology
$1.71
-3.13%
Mkt Cap $93.40M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $125.00K | $11.04M | +8730.40% | -$0.35 | -$0.29 | +17.14% | — | — |
| Q4 2025 Nov 3, 2025 | — | — | — | -$0.36 | -$0.35 | +2.78% | — | — |
| Q3 2025 Aug 14, 2025 | — | $2.82M | — | -$0.36 | -$0.30 | +16.67% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.29 | -$0.35 | -20.69% | — | — |
| Q1 2025 Mar 18, 2025 | — | $3.40M | — | -$0.33 | -$0.32 | +3.03% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.32 | -$0.35 | -9.37% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.33 | -$0.29 | +12.12% | — | — |
| Q2 2024 May 14, 2024 | $4.12M | $16.15M | +291.89% | -$0.27 | -$0.06 | +77.78% | — | — |
| Q1 2024 Mar 21, 2024 | $170.00K | $3.42M | +1911.76% | -$0.49 | -$0.33 | +32.65% | — | — |
| Q4 2023 Nov 7, 2023 | $250.00K | — | — | -$0.57 | -$0.56 | +1.75% | — | — |
| Q3 2023 Aug 11, 2023 | $625.00K | — | — | -$0.66 | -$0.41 | +37.88% | — | — |
| Q2 2023 May 11, 2023 | $620.00K | — | — | -$0.84 | -$0.54 | +35.71% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$0.85 | -$1.04 | -22.35% | — | — |
| Q4 2022 Nov 1, 2022 | — | — | — | -$0.76 | -$0.85 | -11.84% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.68 | -$0.79 | -16.18% | — | — |
| Q2 2022 May 13, 2022 | — | — | — | -$0.62 | -$0.97 | -56.45% | — | — |
| Q1 2022 Mar 29, 2022 | — | — | — | -$0.37 | -$1.98 | -435.14% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.51 | -$8.96 | -1656.86% | — | — |
| Q4 2021 Oct 8, 2021 | — | — | — | — | -$0.26 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$1.66 | — | — | — |